医学
尿路上皮癌
泌尿科
化疗
泌尿系统
上尿路
癌
外科
内科学
膀胱癌
癌症
作者
Thomas van Doeveren,Sebastiaan Remmers,Egbert R. Boevé,Erik B. Cornel,Antoine G. van der Heijden,Kees Hendricksen,Evelyne C. C. Cauberg,Rens A. L. Jacobs,Bin K. Kroon,Anna M. Leliveld,Richard P. Meijer,Harm van Melick,Bob Merks,Jorg R. Oddens,Benjamin Pradère,L.A.J. Roelofs,Diederik M. Somford,Peter de Vries,Bart P. Wijsman,Willemijn A.K.M. Windt
标识
DOI:10.1016/j.eururo.2024.12.006
摘要
Preoperative IIC with mitomycin C was feasible and well tolerated and significantly reduced IVR risk for patients without d-URS. These findings suggest that preoperative IIC is a viable strategy for this subset of UTUC patients and that d-URS should be performed judiciously.
科研通智能强力驱动
Strongly Powered by AbleSci AI